Ovarian Cancer Clinical Trial

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Summary

To determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.

View Full Description

Full Description

Primary Objective:

Determine response rate (RR; complete and partial response [CR, PR]) and duration after therapy with Aroplatinâ„¢ in patients with advanced solid malignancies.

Secondary Objective:

Determine the safety and tolerability of Aroplatin

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Advanced solid malignancies;
Amenable to therapy with DACH platinum agents;
Measurable disease (RECIST criteria);
ECOG performance score of 0-2;
Adequate hematopoietic, liver and renal function;
Adequate cardiac function (maximum of class II, NYHA);
Women of childbearing potential must have a negative urine or serum pregnancy test;
Signed written informed consent;
Subjects must be willing to be followed during the course of treatment/observation and follow-up.

Exclusion Criteria:

No other active malignancies;
No prior therapy with oxaliplatin;
No known brain metastases;
Active, uncontrolled infection or other serious medical illnesses;
Not using or have used any investigational therapy during four weeks before start of protocol treatment.

Study is for people with:

Ovarian Cancer

Phase:

Phase 1

Estimated Enrollment:

40

Study ID:

NCT00057395

Recruitment Status:

Unknown status

Sponsor:

Aronex Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Phase:

Phase 1

Estimated Enrollment:

40

Study ID:

NCT00057395

Recruitment Status:

Unknown status

Sponsor:


Aronex Pharmaceuticals

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider